As providers and healthcare professionals recognize the potential of long-acting injectables to fight the opioid epidemic, many are actively transitioning from oral options to injectables.
Thom Stambaugh, RPh
Advertisement
Articles by Thom Stambaugh, RPh
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
TrumpRx Adds 160 More Drugs: Why the Latest Expansion Matters
2
Report: How Drug Discontinuations Surged Despite Shortage Numbers Declining
3
Danny Williams on What the Next Five Years Hold for Pharma 3PLs
4
How AI and CGTs Are Reshaping Pharma 3PL
5